Thiotepa Riemser האיחוד האירופי - קרואטית - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastična sredstva - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Siklos האיחוד האירופי - קרואטית - EMA (European Medicines Agency)

siklos

theravia - hidroksikarbamid - anemija, sickle cell - antineoplastična sredstva - Шиклоше je indiciran za prevenciju рецидивирующих boli сосудисто-jamice кризов, uključujući akutni sindrom grudnog koša kod djece i odraslih pacijenata koji boluju od simptomatske anemija srpastih stanica sindrom.

TRINOMIA 20 mg/1 kapsula+ 100 mg/1 kapsula+ 2.5 mg/1 kapsula kapsula, tvrda בוסניה והרצגובינה - קרואטית - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

trinomia 20 mg/1 kapsula+ 100 mg/1 kapsula+ 2.5 mg/1 kapsula kapsula, tvrda

amicus pharma d.o.o. - atorvastatin, acetilsalicilna kiselina, ramipril - kapsula, tvrda - 20 mg/1 kapsula+ 100 mg/1 kapsula+ 2.5 mg/1 kapsula - 1 kapsula, tvrda sadrži: 20 mg atorvastatina 100 mg acetilsalicilne kiseline 2,5 mg ramiprila

TRINOMIA 100 mg/1 kapsula+ 20 mg/1 kapsula+ 5 mg/1 kap kapsula, tvrda בוסניה והרצגובינה - קרואטית - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

trinomia 100 mg/1 kapsula+ 20 mg/1 kapsula+ 5 mg/1 kap kapsula, tvrda

amicus pharma d.o.o. - atorvastatin, acetilsalicilna kiselina, ramipril - kapsula, tvrda - 100 mg/1 kapsula+ 20 mg/1 kapsula+ 5 mg/1 kap - 1 kapsula, tvrda sadrži: 20 mg atorvastatina 100 mg acetilsalicilne kiseline 5 mg ramiprila

TRINOMIA 100 mg/1 kapsula+ 20 mg/1 kapsula+ 10 mg/1 kapsula kapsula, tvrda בוסניה והרצגובינה - קרואטית - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

trinomia 100 mg/1 kapsula+ 20 mg/1 kapsula+ 10 mg/1 kapsula kapsula, tvrda

amicus pharma d.o.o. - atorvastatin, acetilsalicilna kiselina, ramipril - kapsula, tvrda - 100 mg/1 kapsula+ 20 mg/1 kapsula+ 10 mg/1 kapsula - 1 kapsula, tvrda sadrži: 100 mg acetilsalicilne kiseline 20 mg atorvastatina 10 mg ramiprila

Opfolda האיחוד האירופי - קרואטית - EMA (European Medicines Agency)

opfolda

amicus therapeutics europe limited - miglustat - vrsta ii za skladištenje glikogena - ostali prehrambeni proizvodi i proizvodi metabolizma - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).

Galafold האיחוד האירופי - קרואטית - EMA (European Medicines Agency)

galafold

amicus therapeutics europe limited - migalastat hydrochloride - fabry-ovu bolest - migalastat - galafold je naznačeno za dugoročno liječenje odraslih i adolescenata u dobi od 16 godina i stariji sa dijagnoze bolesti fabry (α-galaktozidaza manjak) i koji imaju pogodan mutacija.

Pombiliti האיחוד האירופי - קרואטית - EMA (European Medicines Agency)

pombiliti

amicus therapeutics europe limited - cipaglucosidase alfa - vrsta ii za skladištenje glikogena - drugi gastrointestinalni trakt i metabolizam, lijekovi, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).